Run for healthy breasts
On Saturday May 25th our team of runners joined forces at the event “Run for Healthy Breasts“, aimed to support the fight against breast cancer and emphasize the importance of a healthy lifestyle and early prevention. We’re proud to contribute to such a vital cause and run alongside so many inspiring participants. It was a […]
Interview for daily newspaper SME
Read the interview we gave to the daily newspaper SME on the topic of early diagnosis of cancer. We are very grateful for all the support we receive in Slovakia from people who appreciate our work. We promise to persist in our efforts to create a world where cancer will be diagnosed early and thanks […]
Become a part of our success!
Our vision is to create a world where cancer is diagnosed early and treated successfully. We are pleased to announce that we have launched a new investment campaign in which Slovak (as well as foreign) investors can become part of our story. On the Crowdberry platform you can find more information about our achievements so […]
Welcome to the team, Zuzana Batova!
It is a great pleasure for us to introduce our Head of Regulatory and Clinical Affairs, who joined Glycanostics in February this year. Zuzana Batova acted for several years as Head of Slovak Institute for Drug Control and represented Slovakia at EMA. She brings to our team her vast experience, highest level of professionalism and […]
EIC & EuroQuity – Bpifrance Healthcare Investor Day
It was my great pleasure to present Glycanostics® and our early-stage cancer diagnostic test Giasay® at the EIC & EuroQuity – Bpifrance Healthcare Investor Day on 23 October in Paris. It was a great opportunity to meet expert investors looking for the best biotech, pharma, eHealth and medtech companies and take our fundraising journey one step further. Great thanks to the organizers European Innovation Council […]
HealthTech Innovation Days (HTID) – HealthTech For Care
„Glycanostics® is going to be one of 25 most innovative companies that will compete at a pitch competition at the HealthTech Innovation Days (HTID®) in Paris. Please meet our CEO Eva Kovacova in Paris to discuss future of non-invasive cancer diagnostics based on analysis of glycans.” HealhTech Innovation Days (HTID) – HealthTech For Care
European Angel Investment Summit 2023
Meet our CEO Eva Kovacova FCCA at the European Angel Investment Summit in Brussels on 10-11 October! Join me at the premier annual conference where angels, entrepreneurs, and change-makers come together to fuel Europe’s growth: https://lnkd.in/e4MYq4-9 #EAIS23 offers a glimpse into the future, an opportunity to shape tomorrow’s course, and a unique platform to connect with international colleagues who bring […]
EUROPEAN PATENT – EP3775909
First Patent Certificate for EP Patent No. 3 775 909 for us! Availabe here.
New project: € 2.5 mil. funding signed for Novel serological glycan-based biomarkers for screening of breast, lung and pancreatic cancers
The Glycanostics cancer screening technology detects glycan changes (complex carbohydrates) attached to a protein in the blood. It is highly scalable due to the following unique characteristics: detects early-stage cancers that can be missed with imaging techniques (small tumours too); gives quantitative & qualitative info, so we can monitor the disease progress; is affordable, no […]
